Lilly answers insulin price-hike critics with 50% off Humalog generic
admin 4th March 2019 Uncategorised 0Eli Lilly CEO David Ricks may have missed last week’s Senate hearing on drug prices, but he apparently received the message on rising insulin prices. Lilly is now planning a half-priced version of its big-selling insulin Humalog and once again kicked the ball to PBMs.
More: Lilly answers insulin price-hike critics with 50% off Humalog generic
Source: fierce
